Artery Clearance Therapy is a complete program which includes Chelation Therapy, regular exercise, proper nutrition, vitamin and mineral supplementation at therapeutic dosage and avoidance of tobacco and other health-damaging habits.
Safe Health is in technical collaboration with Arterial Disease clinic, Manchester and London(UK) for the use of Artery clearance Therapy for the treatment of vascular diseases.
Chelation comes from the Greek word “claw,” meaning “to grab,” and that’s exactly what chelating agents do. Chelating agents like EDTA travel through the bloodstream “grabbing” on to minerals and metals, such as calcium, lead, mercury, cadmium, copper, aluminum and iron, binding them, removing them from the bloodstream, and delivering them to the kidneys, which excrete them in the urine. Once bound by a chelating agent, the minerals are unable to react in undesirable ways.
The primary use of chelation therapy today is in the prevention and treatment of vascular disease, including atherosclerosis, coronary heart disease and stroke.
Chelation Therapy involves the intravenous infusion of a FDA approved medicine called Ethylene Diamine Tetra-acetic Acid (EDTA)
For whom is it useful?
- Those with Chest Pain
- Those with Heart Disease
- Those who wish to avoid By Pass surgery
- Those who wish to avoid Angioplasty
Artery Clearance Therapy is also useful for those with
- High blood pressure
- Excessive chronic pain
- Memory loss
- Arthritis or other chronic health
- Peripheral Artery Disease (Leg Pain)
- Metal toxicity (Lead, Aluminium, Mercury, Arsenic)
How is Chelation done?
EDTA chelation infusions are administered by slow drip which circulates through the blood stream treating the entire arterial system removing undesirable metals from the body. The frequency of infusion is normally weekly, but may be bi weekly in some cases. The number of infusions depends on the purpose for which Chelation is taken. Ten infusions may be sufficient for preventive purpose, but for relieving symptoms, 20- 30 infusions may be required.
Each patient if different and it is only after a medical evaluation that an individual can be advised on the likely length of treatment. The level of improvement is depends upon the individual patient, the severity of the conditions and the strength of each infusion, which is tailored to each patient.
Mechanisms of action of EDTA
Enhancing antioxidant activity. Free radicals are largely involved in the damage of the cell membranes The more toxic metals in your body, the higher the free radical activity. Heavy metals like lead, iron, copper and calcium multiply those free radicals chain reactions. EDTA can reduce the production of free radicals and prevent their destructive influence and thereby reduce atherosclerotic plaque.
Improving cellular energy production. Calcium that is abnormally deposited in arterial walls inhibits enzyme activity depriving cells of energy. By removing metal ions, EDTA reduces local toxicity and thereby improves enzyme production and function.
Reducing blood “stickiness.” EDTA also acts to directly improve blood platelet function, which is mainly to initiate repair of any damaged internal lining in blood vessels. EDTA appears to inhibit the tendency toward overcoagulation, probably by removing ionic calcium from the platelet membrane..
Normalizing blood cholesterol levels. EDTA treatment results in an increase in high-density lipoproteins (HDL), the “good” cholesterol, and a reduction in low-density lipoproteins (LDL), the “bad” cholesterol.
Removal of calcium from plaque. Calcium that is loosely held in plaque deposits by an electrostatic charge prevents the body from dissolving the plaque. EDTA binds with ionic (free) calcium in blood and thus triggers the release of parathormone. This increases the demand for calcium in blood, and the body responds by drawing from calcium deposits in plaque. With the calcium removed from the plaque, the plaque can be re- absorbed by the body, restoring the artery to its normal status.
Safety and side Effects
Chelation therapy is among the safest of medical procedures. More than 400,000 patients have received over four million treatments during the past 30 years. Not one death has been directly caused by chelation therapy, when properly administered by a physician who was fully trained and competent in the use of this therapy
It is estimated by the American College for Advancement in Medicine, a professional association that supports the use of chelation therapy, that more than 800,000 visits for chelation therapy were made in the United States in 1997 alone.
When used as approved by the FDA (at the appropriate dose and infusion rate) for treatment of heavy metal poisoning, chelation with EDTA has a low occurrence of side effects. The most common side effect is a burning sensation experienced at the site where the EDTA is delivered into the veins. Rare side effects can include fever, hypotension, headache and nausea.
The TACT study by the NIH (USA)
The National Center for Complementary and Alternative Medicine (NCCAM) and the National Heart, Lung, and Blood Institute (NHLBI), both components of the National Institutes of Health (NIH), have launched the Trial To Assess Chelation Therapy (TACT). TACT is the first large-scale, multicenter study to determine the safety and efficacy of EDTA chelation therapy for individuals with coronary artery disease.
CAD is the leading cause of death among men and women in the United States. In spite of effective standard therapies, such as lifestyle modifications, medications, and surgical procedures, some patients with CAD seek out EDTA chelation therapy as a treatment option.
Therefore, NCCAM and NHLBI saw a public health need to conduct a large-scale, well-designed clinical trial that could determine more clearly whether EDTA chelation therapy is indeed an effective and safe alternative for treating CAD. The first participants were enrolled in September 2003 and the study will take approximately 5 years to complete.
Effects of Chelation
Patients routinely report reduction or elimination of their symptoms with an increasing sense of well being after Chelation therapy. Family and friends are often the first to notice and report improvement in appearance, behavior and performance. Comparison of pre- and post- therapy diagnostic tests can provide objective evidence of effectiveness.
The reader is advised that varying and even conflicting views are held by other segments of the medical profession. The information presented in this literature is educational in nature and the patient is requested to consult his treating physician for making decision for management.